BR0008442A - Formulação efervescente farmacêutica, contendo metamizol - Google Patents

Formulação efervescente farmacêutica, contendo metamizol

Info

Publication number
BR0008442A
BR0008442A BR0008442-5A BR0008442A BR0008442A BR 0008442 A BR0008442 A BR 0008442A BR 0008442 A BR0008442 A BR 0008442A BR 0008442 A BR0008442 A BR 0008442A
Authority
BR
Brazil
Prior art keywords
pharmaceutical formulation
metamizole
effervescent pharmaceutical
containing metamizole
formulation
Prior art date
Application number
BR0008442-5A
Other languages
English (en)
Other versions
BR0008442B1 (pt
Inventor
Brigitte Freudenberg
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of BR0008442A publication Critical patent/BR0008442A/pt
Publication of BR0008442B1 publication Critical patent/BR0008442B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: <B>"FORMULAçãO EFERVESCENTE FARMACêUTICA, CONTENDO METAMIZOL"<D>. A invenção refere-se a uma formulação efervescente farmacêutica estável com metamizol e/ou seus sais farmaceuticamente inofensivos como componentes ativo, sendo que o valor do pH da solução correspondente é ácido.
BRPI0008442-5A 1999-02-11 2000-02-10 Composição farmacêutica na forma de formulação efervescente, contendo metamizol BR0008442B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19905581.5 1999-02-11
DE19905581 1999-02-11
PCT/EP2000/001096 WO2000047189A1 (de) 1999-02-11 2000-02-10 Pharmazeutische, metamizol enthaltende brauseformulierung

Publications (2)

Publication Number Publication Date
BR0008442A true BR0008442A (pt) 2001-10-09
BR0008442B1 BR0008442B1 (pt) 2014-04-01

Family

ID=7897089

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0008442-5A BR0008442B1 (pt) 1999-02-11 2000-02-10 Composição farmacêutica na forma de formulação efervescente, contendo metamizol

Country Status (13)

Country Link
EP (1) EP1150660B1 (pt)
JP (1) JP2002536401A (pt)
AT (1) ATE258046T1 (pt)
AU (1) AU777234B2 (pt)
BR (1) BR0008442B1 (pt)
CA (1) CA2362757C (pt)
DE (1) DE50005076D1 (pt)
ES (1) ES2215025T3 (pt)
HU (1) HUP0200336A3 (pt)
PL (1) PL201844B1 (pt)
PT (1) PT1150660E (pt)
TR (1) TR200102279T2 (pt)
WO (1) WO2000047189A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103610656B (zh) * 2013-12-05 2016-02-03 昆明振华制药厂有限公司 一种安乃近片的制备方法
EP3082783A4 (en) * 2013-12-16 2017-08-23 Hypermarcas S.A. Stable oral pharmaceutical composition
CN104434862A (zh) * 2014-11-06 2015-03-25 石家庄正大鸿福牧业有限公司 一种兽用安乃近泡腾片及其制备方法
BG112443A (bg) * 2017-01-19 2018-07-31 Adifarm Ead Ефервесцентен състав, съдържащ метамизол натрий монохидрат и метод за неговото получаване
EP3928766A1 (en) 2020-06-26 2021-12-29 Usso Barnas Pharmaceutical composition and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD41306A (pt) *
JPS52156915A (en) * 1976-06-19 1977-12-27 Hokuriku Pharmaceutical Production of stable injection without blood solubulizing property
IT1265342B1 (it) * 1993-07-19 1996-11-22 Iscofar S A S Di Paolo Ghirard Composizioni farmaceutiche a base di derivati della glicina
AU2387997A (en) * 1997-04-18 1998-11-13 Klinge Pharma Gmbh Stabilized medicaments containing cysteinyl derivatives
DE19822036A1 (de) * 1998-05-15 1999-11-18 Bayer Ag Brausezubereitungen

Also Published As

Publication number Publication date
CA2362757A1 (en) 2000-08-17
HUP0200336A2 (en) 2002-06-29
DE50005076D1 (de) 2004-02-26
PL201844B1 (pl) 2009-05-29
PT1150660E (pt) 2004-06-30
WO2000047189A1 (de) 2000-08-17
JP2002536401A (ja) 2002-10-29
AU777234B2 (en) 2004-10-07
BR0008442B1 (pt) 2014-04-01
CA2362757C (en) 2010-08-24
ES2215025T3 (es) 2004-10-01
ATE258046T1 (de) 2004-02-15
HUP0200336A3 (en) 2005-04-28
AU2804000A (en) 2000-08-29
TR200102279T2 (tr) 2001-11-21
EP1150660A1 (de) 2001-11-07
PL350413A1 (en) 2002-12-02
EP1150660B1 (de) 2004-01-21

Similar Documents

Publication Publication Date Title
BRPI0611400B1 (pt) formulações contendo xiloglicano muco-adesivas úteis em dispositivos médicos e em formulações farmacêuticas
BR0101332A (pt) Formulação oftálmica tópica na forma de uma solução aquosa, e, uso de uma ciclosporina em associação com ácido hialurÈnico ou um de seus sais e com polisorbato 80
CU23367A3 (es) Formulación de moxifloxacino con sal común
BRPI0206636B8 (pt) composição e atividade antiviral de derivados de piperazina azaindoloxoacéticos substituídos, composições farmacêuticas que os contêm e usos
BR0006675A (pt) Derivados de indoloxoacetil piperazina antivirais
BR0109779A (pt) Soluções moleculares hidrofìlicas dispersas de carvedilol
BR0108437A (pt) Piridinil-imidazóis
PT1102579E (pt) Formulacoes de aerossol medicinais
BR0209153A (pt) Indol, azaindol e derivados de amidopiperazina heterocìclicos relacionados
HUP0303082A2 (hu) Szubsztituált indolil-oxo-acetil-piperazinszármazékok, ezeket tartalmazó készítmények és vírusellenes alkalmazásuk
PT1255557E (pt) Preparacao farmaceutica estavel de aplicacao nasal oral ou sub-lingual contendo desmopressina
CO5180582A1 (es) Soluciones farmaceuticas de levosimendan
BR9915694A (pt) Composições compreendendo cefuroxima axetil
BR0116060A (pt) Composição farmacêutica de dronedarona para administração parenteral
BR0008442A (pt) Formulação efervescente farmacêutica, contendo metamizol
BR0212031A (pt) Preparados de combinação de derivados de 1,1-dióxido de 1-4-benzotiepina com outras substâncias ativas e seu emprego
BR9914929A (pt) Fenil - alquenoil - guanidinas substituìdas de ácido biliar, processos para a sua preparação, sua aplicação como medicamentos ou agentes diagnósticos, assim como medicamento contendo as mesmas
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
HRP20010764B1 (en) Prucalopride oral solution
BR0100228A (pt) Macrolìdeos com 13 e 14 elementos antibacterianos e procinéticos e seus intermediários
BR0214487A (pt) Composição farmacêutica que compreende uma combinação de metformina e um ácido 4-oxobutanóico, e o uso da mesma para o tratamento de diabetes
BR0014233A (pt) Conjugados de 4-benzilaminoquinolina com ácido galênico e seus heteroanálogos, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação
IT1306147B1 (it) Derivati di principi attivi ad attivita&#39; terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
ES2131482B1 (es) Formulacion acuosa de bambuterol.
BR0113055A (pt) Preparação sólida altamente absorvìvel

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIDO O PEDIDO COM BASE NOS ARTIGOS 8O E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/04/2014, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time
B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)